CLAY CARTER: Open Payments
NPI 1639726938 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,183 in 43 payments from 11 companies in 2025. Trend: 2023 $499 · 2024 $651 · 2025 $1,183
Food & beverage: $1,183
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 19 | $636 |
| Regeneron Healthcare Solutions, Inc. | 4 | $199 |
| ABBVIE INC. | 8 | $139 |
| Arcutis Biotherapeutics, Inc. | 4 | $60 |
| GENZYME CORPORATION | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Incyte Corporation | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| Amgen Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
Products named: NEMLUVIO, DUPIXENT, SKYRIZI, Zoryve, RINVOQ, SPEVIGO, OPZELURA, COSENTYX.
Industry payments across KY — which companies pay providers there.
